 Home > Medical News > Latest Medical News > The cost of raw materials such as windbreak soared, and the profit of Zhongsheng Pharmaceutical fell!

The cost of raw materials such as windbreak soared, and the profit of Zhongsheng Pharmaceutical fell!

 Last Update: 2022-10-31
 Source: Internet
 Author: User

Tags

start soap business

red tattoo ink

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Guangdong Zhongsheng Pharmaceutical Co.
, Ltd.
(Zhongsheng Pharmaceutical, code: 002317.
SZ) 2022 half-year performance report shows that from January 1, 2022 to June 30, 2022, the company achieved operating income of 1.
326 billion yuan, a year-on-year increase of 9.
57%, a net profit of 202 million yuan, a year-on-year decrease of 29.
73%, and basic earnings per share of 0.
25 yuan
.
According to the company's 2021 annual report, during the reporting period, the company achieved operating income of 2.
429 billion yuan, a year-on-year increase of 28.
13%.

Chart: Core operating data of Zhongsheng Pharmaceutical from 2016 to 2021

First, Zhongsheng Pharmaceutical makes efforts to clear heat and detoxify the track

Zhongsheng Pharmaceutical's products involve ophthalmology, cardiovascular and cerebrovascular, respiratory, digestion and other therapeutic fields, with proprietary Chinese medicine as the cornerstone of business, and the core proprietary Chinese medicines include compound thrombotic tong, cerebral embolism, compound salvia tablets, Zhongsheng pill series, clear heat and dehumidification granules, etc
.
According to the annual report data, in 2021, Zhongsheng Pharmaceutical's proprietary Chinese medicine products achieved sales revenue of 156,058.
61 million yuan, a year-on-year increase of 34.
45%.

According to data from Intranet, the total sales of Zhongsheng Pharmaceutical's compound thrombosis in the three major terminals in 2021 reached 860 million yuan, and in the market of proprietary Chinese medicine for heat clearing and detoxification, the total sales of Zhongsheng series products in the three major terminals in 2020 also exceeded 100 million yuan
.
The exclusive product Zhongsheng Pill has a high market position in the terminals of physical pharmacies in Chinese cities, and is expected to rank sixteenth
in the list of internal brands of detoxification and detoxification drugs in 2021.

In this issue, the big data platform of TCM industry of Tiandi Yuntu makes a brief analysis
of the cost pressure of traditional Chinese medicine raw materials of enterprises from the perspective of raw materials involved in Zhongsheng Pill.

Second, the core raw materials of sentient beings pills

Table 1: Core raw materials of Zhongsheng Pills

Zhongsheng pills can clear heat and detoxify, activate blood and cool blood, anti-inflammatory and pain-relieving, and are used for upper respiratory tract infections, acute and chronic pharyngitis, acute tonsillitis and other symptoms
.

Third, the rise and fall of the price of raw materials for Zhongsheng Pills

Table 2: Rise and fall of raw materials of Zhongsheng Pills (yuan/kg)

From January 2021 to October 2022, the price of 12 raw material varieties increased, accounting for 70%, the price of 4 raw materials decreased, accounting for 24%, and the price of 1 raw material was flat, accounting for 6%.

Fourth, the market of raw materials of Zhongsheng Pills

Dandelion, a low-priced variety, is planted in a small area, and this year's wild production areas such as Gansu have suffered drought, and the output is limited
.
The price of the early stage rises, there are batch supply transactions in the near future, merchants actively sell, the market is running firmly, the price of spot wild goods is between 13-14 yuan (kg price, the same below), and the price of home seed goods merchants is around 7.
5 yuan
.
At present, there are not many sources of goods in the market, and the future market is worth paying attention to
.

Windproof, new production continues, the production area is not fast due to the impact of the epidemic, the market source of goods is sold smoothly, the market performance is firm, the current market sowing windproof more shouting price at 30 yuan, seed sowing windproof more shouting price at 33 yuan, merchants pay close attention to this year's
source output.

Purple Flower Diding, the demand is stable, the source of goods is in a normal state of purchase and sales, the recent market and the previous period of stability, the current market Purple Flower Ding machine pressing package price between 8-9.
5 yuan, the overall inventory is normal, the market attention is not high, it is expected that there will be no major changes
in the market in the short term.

Skullcap, new production continues, the overall output is expected to be large, the market attention is weakened, and the source of goods is mainly
based on actual demand.
Due to the abundant inventory for sale, many merchants actively sell, the market is slightly weak, the current market price of Shanxi skullcap is 18-22 yuan, Shanxi skullcap slices are priced at 23-26.
5 yuan
.

Red peony, the attention has weakened, and the recent demand is mainly
based on actual sales.
Due to the abundant supply, active sales of many merchants, and stable operation of the market, the current market price of Inner Mongolia red peony is 18-20 yuan, Inner Mongolia red peony is priced at 22-25 yuan, Inner Mongolia selected red peony is priced at 36-39 yuan, Shaanxi red peony is priced at 16-19 yuan, Shaanxi red peony is priced at 19-21 yuan, and Shaanxi selected red peony is priced at 26-30 yuan
.

Smallpox pollen, Bozhou production area began to produce new, the output of new goods is not large, the market popularity is rapidly agglomerated, multi-business organization of the source of goods, driving the source of goods to accelerate
sales.
Due to the weak inventory, the market is steadily rising, and the current market price of Hebei smallpox powder is 40-42 yuan, Hebei smallpox powder is priced at 46-50 yuan, and Jiangsu smallpox powder is priced at 33-36 yuan
.

Xuan ginseng, now the peak demand season, merchants ask / buy in batches, but the overall transaction volume is still not large, the market supply is abundant, the market fluctuates slightly, the price of Hubei unified goods is between 11-12 yuan, the price of good goods is 12-13 yuan, and the price of unified films is 13-14 yuan
.
The overall attention of this variety is not high, and the market is expected to flatten
.

Soap horn, new goods are listed one after another after the production of new products, due to the low price, some merchants actively purchase, resulting in an increase in the price of the production area; The market supply is stable, the recent merchants buy in small quantities, the market has not changed significantly, the current market small unified goods price between 22-23 yuan, the general price of medium thorn tablets is around 35 yuan
.

Bai Zhi, affected by last year's high prices, this year's source of output is sufficient, but the processing of sulfur-free goods is less, resulting in the market performance of this specification is firm, the current market price of small unified goods is 15-16 yuan, sulfur containing goods are sufficient, and the price of small unified goods is 12-13 yuan
.

5.
Comprehensive reviews

1.
Windproof and other varieties of procurement cost pressure is relatively high Raw material pressure test shows that the current raw materials of Zhongsheng pills mainly come from windproof, angelica, smallpox pollen, white root, etc.
from the perspective of supply pressure; From the perspective of quality pressure, it mainly comes from windproof, dandelion and bezoar
.

2.
Gangmeigen wild resources are not valued This variety is a bulk rigid demand for traditional Chinese medicine raw materials, but because it is a southern medicine species, it has never been valued by hoarders, so the market fluctuations in the past 20 years are not obvious
.

However, in the past five years or so, on the one hand, because Gangmeigen is a perennial wild plant, it has only been artificially planted on a small scale in western Guangdong and other places, and the resources are difficult to sustain.

As a result, its resource development area has gradually extended from the core production areas of Guangdong, and it has to seek resource imports from abroad; On the other hand, the cost of rural labor is rising; Third, the annual demand for Gangmeigen is more than 30,000 tons, far exceeding most domestic varieties, and the rigid demand is very obvious
.
Therefore, we believe that the price of Gangmegan will slowly rise in the future
, even if there is no hype.

In summary, the cost of raw materials of proprietary Chinese medicines is affected by natural factors, market price fluctuations, etc.
, and it is difficult to regulate and control, in order to avoid the supply of centralized procurement, most enterprises will take into account uncontrollable factors such as raw material costs when quoting, it is expected that the short-term price reduction brought by the centralized procurement of proprietary Chinese medicines is relatively moderate, and in the long run, the centralized procurement of proprietary Chinese medicines is beneficial to leading enterprises of proprietary Chinese medicines with high-quality resources, and the industry concentration is expected to continue to optimize
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.